Provided by Tiger Trade Technology Pte. Ltd.

CSPC PHARMA

9.230
-0.010-0.11%
Volume:59.56M
Turnover:549.93M
Market Cap:106.35B
PE:23.29
High:9.320
Open:9.130
Low:9.110
Close:9.240
52wk High:11.203
52wk Low:6.387
Shares:11.52B
HK Float Shares:11.52B
Volume Ratio:0.46
T/O Rate:0.52%
Dividend:0.29
Dividend Rate:3.14%
EPS(LYR):0.396
ROE:20.90%
ROA:10.70%
PB:2.42
PE(LYR):23.29
PS:2.91

Loading ...

Movement Alert|CSPC PHARMA Rises 3.57% in Regular Trading, AstraZeneca siRNA Collaboration $30 Million Upfront Payment Received

Market Focus
·
Aug 13

CSPC Pharmaceutical Changes Trustee for 2018 Share Award Scheme to BOCI Trustee Hong Kong

Reuters
·
Aug 12

CSPC Pharmaceutical Group Announces Change in Trustee for 2018 Share Award Scheme

Stock News
·
Aug 12

CSPC Pharmaceutical Receives USD 30 Million Upfront Payment from AstraZeneca Under siRNA Pact

Reuters
·
Aug 12

CSPC Pharmaceutical - Receives US$30 Mln Upfront Payment from AstraZeneca on Aug 12 2026 Under Collaboration Agreement

THOMSON REUTERS
·
Aug 12

CSPC Pharma Starts Phase 1 Trial of CAR-T Drug for Relapsed, Refractory Lupus

MT Newswires Live
·
Aug 12

CSPC Pharma's SYS 6063 Trial for Lupus Clears First Site in China

Stock News
·
Aug 11

CSPC Pharmaceutical - Pharma Initiates Phase I Trial of Sys6063 for Relapsed, Refractory Sle in China

THOMSON REUTERS
·
Aug 11

Movement Alert|CSPC PHARMA Rises 3.19% in Regular Trading, Monkeypox mRNA Vaccine Receives FDA Clinical Trial Approval

Market Focus
·
Aug 11

CSPC Pharmaceutical's Mpox Vaccine Candidate Gets Trial Approval from US FDA

MT Newswires Live
·
Aug 10

CSPC Pharma Sets 20 Aug 2026 Board Meeting to Approve 1H 2026 Interim Results

Bulletin Express
·
Aug 10

CSPC Pharma (01093) Receives FDA Clearance for US Clinical Trial of Monkeypox mRNA Vaccine

Stock News
·
Aug 10

CSPC Says FDA Clears US Clinical Trial for SYS 6037 Mpox mRNA Vaccine

Reuters
·
Aug 10

CSPC Pharmaceutical - Sys6037 Mpox Mrna Vaccine Obtains FDA Clinical Trial Approval in U.S.

THOMSON REUTERS
·
Aug 10

Movement Alert|CSPC PHARMA Rises 4.43% in Regular Trading, AstraZeneca Collaboration Deepens with Milestone Payment and Joint Venture

Market Focus
·
Aug 10

CSPC Pharmaceutical Group Stock Advances 1.5% in Hong Kong, Outperforms Competitors

Dow Jones
·
Aug 06

Hong Kong Stock Exchange News Highlights: Beone Medicines Sees 111% Surge in Adjusted Net Profit for First Half of the Year

Stock News
·
Aug 06

CSPC Pharma Secures US$10.00 million Milestone Payment from AstraZeneca under Small-Molecule R&D Pact

Bulletin Express
·
Aug 05

CSPC Pharmaceutical Receives USD 10 Million AstraZeneca Milestone Payment Under Research Pact

Reuters
·
Aug 05

CSPC Pharma and AstraZeneca to Establish 51/49 Joint Venture for Next-Generation Biologics Facility in Shijiazhuang

Bulletin Express
·
Aug 05